Commentary: The new ESC guidelines for the diagnosis and management of chronic coronary syndromes

被引:6
作者
Camici, P. G. [1 ,2 ]
Crea, F. [3 ,4 ]
Ferrari, R. [5 ,6 ]
机构
[1] Univ Vita Salute San Raffaele, Via Olgettina 60, I-20132 Milan, Italy
[2] Osped San Raffaele, Via Olgettina 60, I-20132 Milan, Italy
[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Thorac Sci, Rome, Italy
[5] Univ Ferrara, Ctr Cardiol, Ferrara, Italy
[6] Maria Cecilia Hosp, GVM Care & Res, Cotignola, RA, Italy
关键词
VENTRICULAR SYSTOLIC DYSFUNCTION; ARTERY-DISEASE; MICROVASCULAR DYSFUNCTION; STABLE ANGINA; IVABRADINE; BEAUTIFUL; OUTCOMES;
D O I
10.1016/j.ijcard.2019.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:19 / 21
页数:3
相关论文
共 19 条
[1]   Treatment of Angina: Where Are We? [J].
Balla, Cristina ;
Pavasini, Rita ;
Ferrari, Roberto .
CARDIOLOGY, 2018, 140 (01) :52-67
[2]   Medical progress - Coronary microvascular dysfunction [J].
Camici, Paolo G. ;
Crea, Filippo .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :830-840
[3]   Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization [J].
Crea, Filippo ;
Merz, Cathleen Noel Bairey ;
Beltrame, John F. ;
Berry, Colin ;
Camici, Paolo G. ;
Kaski, Juan Carlos ;
Ong, Peter ;
Pepine, Carl J. ;
Sechtem, Udo ;
Shimokawa, Hiroaki .
EUROPEAN HEART JOURNAL, 2019, 40 (29) :2455-+
[4]   Coronary microvascular dysfunction: an update [J].
Crea, Filippo ;
Camici, Paolo G. ;
Merz, Cathleen Noel Bairey .
EUROPEAN HEART JOURNAL, 2014, 35 (17) :1101-+
[5]   Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment [J].
Ferrari, Roberto ;
Pavasini, Rita ;
Camici, Paolo G. ;
Crea, Filippo ;
Danchin, Nicolas ;
Pinto, Fausto ;
Manolis, Athanasios ;
Marzilli, Mario ;
Rosano, Giuseppe M. C. ;
Lopez-Sendon, Jose ;
Fox, Kim .
EUROPEAN HEART JOURNAL, 2019, 40 (02) :190-+
[6]   A 'diamond' approach to personalized treatment of angina [J].
Ferrari, Roberto ;
Camici, Paolo G. ;
Crea, Filippo ;
Danchin, Nicolas ;
Fox, Kim ;
Maggioni, Aldo P. ;
Manolis, Athanasios J. ;
Marzilli, Mario ;
Rosano, Giuseppe M. C. ;
Lopez-Sendon, Jose L. .
NATURE REVIEWS CARDIOLOGY, 2018, 15 (02) :120-132
[7]   Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial [J].
Fox, Kim ;
Ford, Ian ;
Steg, P. Gabriel ;
Tendera, Michal ;
Ferrari, Roberto .
LANCET, 2008, 372 (9641) :807-816
[8]   Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure [J].
Fox, Kim ;
Ford, Ian ;
Steg, Philippe Gabriel ;
Tardif, Jean-Claude ;
Tendera, Michal ;
Ferrari, Roberto .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (12) :1091-1099
[9]   Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial [J].
Fox, Kim ;
Ford, Ian ;
Steg, Ph. Gabriel ;
Tendera, Michal ;
Robertson, Michele ;
Ferraris, Roberto .
EUROPEAN HEART JOURNAL, 2009, 30 (19) :2337-2345
[10]   2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J].
Ibanez, Borja ;
James, Stefan ;
Agewall, Stefan ;
Antunes, Manuel J. ;
Bucciarelli-Ducci, Chiara ;
Bueno, Hector ;
Caforio, Alida L. P. ;
Crea, Filippo ;
Goudevenos, John A. ;
Halvorsen, Sigrun ;
Hindricks, Gerhard ;
Kastrati, Adnan ;
Lenzen, Mattie J. ;
Prescott, Eva ;
Roffi, Marco ;
Valgimigli, Marco ;
Varenhorst, Christoph ;
Vranckx, Pascal ;
Widimsky, Petr .
KARDIOLOGIA POLSKA, 2018, 76 (02) :229-313